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Abstract
GATA4 confers cell type-specific gene expression on genes expressed in cardiovascular, gastro-intestinal, endocrine and
neuronal tissues by interacting with various ubiquitous and cell-type-restricted transcriptional regulators. By using yeast
two-hybrid screening approach, we have identified PIAS1 as an intestine-expressed GATA4 interacting protein. The physical
interaction between GATA4 and PIAS1 was confirmed in mammalian cells by coimmunoprecipitation and two-hybrid
analysis. The interacting domains were mapped to the second zinc finger and the adjacent C-terminal basic region of GATA4
and the RING finger and the adjoining C-terminal 60 amino acids of PIAS1. PIAS1 and GATA4 synergistically activated IFABP
and SI promoters but not LPH promoters suggesting that PIAS1 differentially activates GATA4 targeted promoters. In
primary murine enterocytes PIAS1 was recruited to the GATA4-regulated IFABP promoter. PIAS1 promoted SUMO-1
modification of GATA4 on lysine 366. However, sumoylation was not required for the nuclear localization and stability of
GATA4. Further, neither GATA4 sumoylation nor the SUMO ligase activity of PIAS1 was required for coactivation of IFABP
promoter by GATA4 and PIAS1. Together, our results demonstrate that PIAS1 is a SUMO ligase for GATA4 that differentially
regulates GATA4 transcriptional activity independent of SUMO ligase activity and GATA4 sumoylation.
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Introduction
GATA factors are zinc finger-containing transcription factors
that play an important role in developmental processes, tissue
differentiation and cell-type specific gene expression. Based on
sequence similarity and expression pattern, GATA factors are
grouped into 2 subgroups: GATA1/2/3 are mostly expressed in
hematopoietic tissues and GATA4/5/6 are expressed in meso-
dermally- and endodermally-derived tissues such as, heart,
vasculature, lungs, liver, intestines, gonads and various endocrine
glands [1]. In the intestine GATA4 is expressed in a rostro-caudal
gradient with a strongest expression in the duodenum and the
jejunum and decreasing expression along the length of ileum and
undetectable in colon [2–4]. GATA4 also exhibits a gradient
expression along the crypt-villus axis [2,3,5–7]. Strong GATA4
expression is detected in terminally differentiated cells at the villus
tip and in differentiating cells along the sides of the villi suggesting
that GATA4 expression is associated with enterocyte differentia-
tion.
In support of the role of GATA4 in enterocyte differentiation,
GATA4 binding sites are present in the regulatory regions of
several enterocyte expressed genes such as, lactase-phlorizin
hydrolase (LPH) [8], sucrose isomaltase (SI) [6], intestinal fatty
acid binding protein (IFABP/FABP-2) [5,7], liver type fatty acid
binding protein (LFABP/FABP-1) [9], claudin-2 [10], intestinal
alkaline phosphatase (IAP) [5]. GATA4 binds to these sites and
GATA4 binding has been shown to be essential for the expression
of promoters of these differentiation marker genes. In intestine-
specific GATA4 knockout animals the expression of FABP-1, LPH
and various genes characteristic of jejunal epithelial transcriptome
were downregulated in jejunum confirming the obligatory role of
GATA4 in gut epithelial gene expression [2,3]. Interestingly,
several ileal epithelium-specific genes including apical sodium-
dependent bile acid transporter (ASBT) and ileal lipid binding
protein (ILBP), were upregulated in the jejunal epithelium in these
animals suggesting that GATA4 plays a pivotal role in establishing
the small intestinal segment identity by promoting jejunal-specific
gene program while simultaneously repressing ileal-specific-gene
program [2,3].
GATA4 plays a central role in tissue-specific gene expression in
various other tissue types such as, heart, gonads, and neuroendo-
crine tissues [1,11–14]. Studies examining the mechanisms by
which GATA4 contributes to tissue specific-gene expression in
different tissue types have established that the ability of GATA4 to
combinatorially interact with various ubiquitous and tissue-
restricted factors is the basis by which GATA4 drives tissue- and
cell type-specific gene program. GATA4 has been shown to
physically and/or functionally interact with several GI tissue-
expressed factors such as HNF-1a [6,9,15,16], HNF4 alpha [17],
Fog1/2 [18–20], GATA5 [21], Cdx-2 [6,22] and the TGFb signal
transducing Smads [5] to regulate gene expression in GI tissues. In
this study we sought to identify additional GATA4 interacting
proteins expressed in the GI tissue using the yeast two-hybrid
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(signal transducer and activator of transcription 1) [PIAS1], a
protein with small ubiquitin related modifier (SUMO) ligase
activity, as a small intestine-expressed GATA4 interacting protein
and show that PIAS1 physically interacts with GATA4 and
synergistically enhances GATA4 transcriptional activity on
intestinal gene promoters such as IFABP and SI but not LPH.
Further, we show that PIAS1 promotes GATA4 sumoylation on
lysine 366 in agreement with a previous report [23]. However, in
contrast to this previous report we show that in intestinal epithelial
cells nuclear localization and transcriptional activity of GATA4
are independent of sumoylation and neither PIAS1 SUMO ligase
activity nor GATA4 sumoylation are required for coactivation of
intestinal epithelium expressed IFABP promoter.
Materials and Methods
Ethics statement
Animal experiments described herein were approved by the
Baylor College of Medicine institutional animal care and use
committee (protocol number AN-2825).
Plasmids
Wild type and 240 GATA site mutated IFABP-luciferase
reporter, and wild type and deletion mutants of GATA4 have been
reported earlier [5]. Lactase phlorizin hydrolase (LPH)-luciferase
reporter was constructed by cloning PCR generated 2399 to +14
region of human LPH gene into KpnI-BglII sites of pGL2 basic
vector. Sucrase isomaltase (SI)-luciferase reporter was similarly
generated by cloning 2342 to +30 fragment into MluI-XhoI sites
of pGL2 basic vector. The murine PIAS1 expression vector,
pCMVPIAS1, was a kind gift from K. Shuai [24]. FLAG tagged
PIAS1 and deletion mutants of PIAS1 expressing different
domains of PIAS1 (1–150, 1–480, 121–480, 300–480, 300–650
and 450 to 650) were constructed using PCR in the vector
pCMVTag2C. The mammalian two-hybrid Gal4 DNA binding
domain-G4 plasmid was generated by ligating a PCR amplified rat
GATA4 fragment (amino acids 191–445) into SalI-XbaI sites of
the pBIND vector (Promega). Similarly, VP16 activation domain
fused to PIAS1 was constructed by ligating PIAS1 fragment
(amino acids 12 to 511) into BamHI sites of the activation domain
vector, pACT (Promega). Sequences of all the primers used for
plasmid construction are listed in Table S1.
Site directed mutagenesis
Site directed mutagenesis of GATA4 and PIAS-1 was
performed using the Quick-change II XL kit (Stratagene). The
SUMO acceptor lysine 366 of GATA4 was mutated to arginine
and the cysteine 350 within the catalytic RING domain of PIAS1
was mutated to serine. Sequences of mutagenic primers are listed
in Table S1.
Two-hybrid screening
Yeast two-hybrid screening was performed using the Match-
maker Gal4 two-hybrid system 3 (Clontech) according to
manufacturer’s instructions. The bait vector was constructed by
subcloning a PCR generated rat GATA4 fragment (amino acids
191–445) in-frame with the Gal4 DNA binding domain in the
yeast pGBKT7 expression vector. This GATA4 fragment has both
zinc fingers and the C-terminal domain but lacks the N-terminal
activation domains. The bait vector and human small intestinal
cDNA library fused to Gal4 activation domain were transformed
into the yeast strain AH109 and transformants were selected for
growth on triple drop out media (2Trp1/2Leu2/2His3) and
activation of a-galactosidase. Surviving colonies were streaked on
quadruple dropout media (2Trp1/2Leu2/2His3/2Ade2) and
the plasmid DNA from the clones that survived this second round
of stringent screening were rescued, retransformed along with the
bait into yeast strain AH109 to confirm interactions. Rescued
plasmids were sequenced and the sequences were searched against
GenBank entries to identify GATA4-interacting proteins.
Cell culture and transfections
HCT116 colon cancer cells were purchased from ATCC and
maintained in McCoy’s 5A medium supplemented with 10% fetal
bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin and
2 mM L-glutamine. Transient transfection experiments were
performed by cotransfecting subconfluent cells with 0.2 mgo f
IFABP, SI and lactase promoter-luciferase vectors with 0.2 mgt o
0.4 mg of GATA4 and PIAS-1 expression vectors. pCDNA3
empty vector was used to keep the total amount of transfected
DNA constant.
Chromatin immunoprecipitation (ChIP)
ChIP assays were performed on isolated mouse jejunal villus
epithelium using a ChIP assay kit as described earlier [25]. Jejunal
villus epithelium was isolated as described by Gu et al [26]. Briefly,
jejunum from euthanized 6–8 week-old mice were opened and
flushed several times using ice-cold PBS containing protease
inhibitors to remove debris. The jejunum was cut into 1–2 cm
segments, placed in ice-cold BSS buffer containing protease
inhibitors, vortexed at maximum speed for 5 minutes and the
supernatant containing mostly debris and a few villi was separated
from the pellet by allowing the suspension to stand for 3 minutes.
The pellet was suspended in fresh BSS buffer, vortexed for
5 minutes and passed through a 500 m steel mesh (Spectrum
Labs). The flow through containing the villi and a few crypts were
pelleted, washed twice in HBSS and suspended in HBSS. ChIP
assays were performed using a ChIP assay kit (Upstate/Millipore)
using 5 mg of goat PIAS1 antibody (Santacruz Biotechnology) or
nonimmune goat antibody (negative control) or acetyl histone H3
antibody (positive control). Chromatin immunoprecipitates were
analyzed by semiquantitative PCR using primers corresponding to
the promoter region (2306 and +24) or the exon 3 to exon 4
region (+3328 to +3981) of mouse IFABP gene. Sequences of
primers used for ChIP assays are listed in supplementary data
table 1.
In vitro translation and GST pull-down assays
In vitro translations were performed using coupled rabbit
reticulocyte in vitro transcription-translation system (Promega)
according to manufacturer’s instructions. GST pulldown experi-
ments were performed as described earlier [5] using bacterially
expressed, GST fused GATA4 and PIAS-1 proteins and
35 [S]-
methionine labeled in vitro translated wild-type and mutated
GATA4 and PIAS-1 proteins.
Immunoprecipitation (IP) and western blotting (WB)
IP and WB experiments were done as described earlier [5],
using lysates prepared from HCT116 cells transiently transfected
with HA epitope tagged GATA4 and FLAG epitope tagged PIAS-
1. While preparing lysates for in vivo sumoylation assays, N-ethyl
maleimide was added to the lysis buffer to a final concentration of
20 mM. For immunoprecipitation of endogenous GATA4, 1 mg
of lysates prepared from subconfluent IEC-6 cells were immuno-
precipitated with 5 mg of goat GATA4 antibody (Santacruz
Biotechnology) or non-immune goat control antibody. IPs were
PIAS1 Is a GATA4 Coactivator
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antibody (Cell Signaling) and mouse GATA4 antibody (Santacruz
Biotechnology).
Immunofluorescence
HCT 116 cells were plated in 6-well plates containing sterile
coverslips and transfected with HA epitope tagged wild-type or
K366R mutated GATA4. Thirty six hours posttransfection, cells
were fixed in 2% paraformaldehyde and permeabilized with 0.2%
triton X-100. Coverslips were washed in PBS and blocked with
5% horse serum for 1 hour at room temperature. Coverslips were
incubated with 1:500 diluted rabbit HA antibody in blocking
buffer for 1 hour at room temperature, washed 5 times in PBS and
incubated with secondary antibody (goat anti rabbit antibody)
conjugated to Alexa 594. Coverslips were washed in PBS,
mounted in DAPI-containing mounting media and photographed
using BX50 microscope (Olympus, Center Valley, PA, USA)
equipped with a CCD camera.
Statistics
All numerical results are presented as mean 6 SE. The
statistical significance of differences was analyzed using Student’s t
test. P,0.05 was considered statistically significant.
Figure 1. GATA4 and PIAS1 interact in yeast and mammalian cells. Panel A. The bait vector and the longest PIAS1 prey clone captured in
the yeast two-hybrid screen are depicted diagrammatically. The numbers correspond to amino acids of the full length GATA4 and PIAS1 proteins.
Abbreviations: Gal4DBD: Gal4 DNA binding domain; Gal4AD: Gal4 activation domain. Panel B. Yeast colonies transformed with rescued Gal4DBD-
GATA4 (top panel) or Gal4AD-PIAS1 (middle panel) vectors or cotransformed with both (bottom panel) were streaked on quadruple dropout media.
Panel C. HCT116 cells were transfected with HA epitope tagged GATA4 (lane 1) or FLAG epitope tagged PIAS1 (lane 2) or both (lane 3). Equal
amounts of total protein lysates were immunoprecipitated with HA antibody and probed with FLAG antibody (top panel) or immunoprecipitated
with FLAG antibody and probed with HA antibody (second panel). Third and fourth panels correspond respectively to western blots of input lysates
with HA antibody and FLAG antibody. In the top panel, asterisk and arrow indicates nonspecific bands and the specific band, respectively. Panel D.
Subconfluent HCT116 cells were transfected with Gal4 DNA binding site controlled minimal promoter luciferase reporter (G5Luc) along with vectors
expressing Gal4 DNA binding domain (DBD) or Gal4 DBD fused to GATA4 or VP16 activation domain or VP16 activation domain fused to PIAS1 alone
or in combinations as indicated. Lysates were assayed for luciferase activity 48 hours post-transfection and normalized to total protein. Fold
activation over that of G5Luc activity, which was set as one was calculated. Results from 3 experiments done in triplicates are shown as mean6SEM.
*p,0.05.
doi:10.1371/journal.pone.0035717.g001
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PIAS1 interacts with GATA4
To identify proteins that interact with GATA4, we used a Gal4
based yeast two-hybrid screen in which GATA4 fused to the Gal4
DNA binding domain was used as a bait and an intestinal library
fused to Gal4 activation domain was used as prey (Figure 1A).
PIAS1 appeared multiple times in the screen and the longest
PIAS1 clone had 496 amino acids (amino acids 11 to 507) that
contained a partial N-terminal SAP domain and the entire RING
finger domain. Physical association between GATA4 and PIAS1
in yeast was confirmed by growth of colonies on stringent
quadruple drop out media (2Trp1/2Leu2/2His3/2Ade2)
[Figure 1B] and activation of a-galactosidase (data not shown)
when the rescued GATA4 and PIAS1 vectors were transformed
together but not individually into yeast AH109 strain. To
demonstrate that GATA4 and PIAS1 physically interact in
mammalian cells, we performed coimmunoprecipitation experi-
ments in HCT116 colon cancer cells by overexpressing HA
epitope tagged GATA4 and FLAG epitope tagged PIAS1. As
shown in the figure 1C, FLAGPIAS1 was detected in the
immunoprecipitate of HAGATA4 and in converse experiments,
HAGATA4 was detected in the immunoprecipitate of FLAG-
PIAS1 only when the 2 expression plasmids were coexpressed. We
further confirmed the interaction between GATA4 and PIAS1 by
using mammalian two-hybrid assays. Transfection of HCT116
cells with the GAL4 DNA binding domain fused GATA4 and the
VP16 activation domain fused PIAS1 together but not individually
resulted in a strong expression of the cotransfected GAL4 DNA
binding site regulated luciferase reporter suggesting that GATA4
and PIAS1 interact in vivo (Figure 1D).
Figure 2. Second zinc finger and the adjacent basic region of GATA4 and the RING finger and the adjoining C-terminal sequences
of PIAS1 mediate physical association. GST pull down experiments were performed using [
35S] methionine labeled wild-type or indicated
mutants of PIAS1 and purified GST fused GATA4 protein or GST protein immobilized on glutathione-sepharose beads (panel A). In panel B,
converse experiments in which purified GST or GST fused PIAS1 protein immobilized on glutathione beads were used to pull down [
35S] methionine
labeled wild-type or indicated mutants of GATA4 protein is shown. The domains present in deletion mutants are diagrammatically indicated. The
asterisk embedded in the RING domain of PIAS1m indicates that this protein carries a C350S mutation that inactivates the SUMO ligase activity.
doi:10.1371/journal.pone.0035717.g002
Figure 3. PIAS1 binds to IFABP promoter in isolated murine
villus epithelial cells. Cross-linked chromatin isolated from murine
villus epithelial cells were sheared and immunoprecipitated with
acetylated histone H3 antibody (lane 2), no antibody (lane 3),
nonimmune goat antibody (lane 4) and PIAS1 antibody (lane 5). The
chromatin immunoprecipitates were purified, reverse cross-linked and
analyzed by semiquantitative PCR with primers corresponding to IFABP
promoter (panel A) or primers from 39 region of the IFABP gene
(panel B). Lane 1 is input control (5%). Lane 6 is water control for used
during the PCR reaction. Size marker was run in lane 7. In panel C, the
nucleotide coordinates of the primers with respect to IFABP genomic
clone (GenBank accession # M65033) is shown. Cap site, exons and the
poly(A) signal are indicated.
doi:10.1371/journal.pone.0035717.g003
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region of GATA4 and the RING finger domain and the
adjacent C-terminal region of PIAS1 mediate the physical
interaction between GATA4 and PIAS1
We used GST pull-down assays to map the protein domains
that mediate the physical interaction between GATA4 and PIAS1.
Purified GST or GST-GATA4 fusion proteins were immobilized
on glutathione-agarose beads and examined for their ability to
interact with
35[S] methionine labeled in vitro translated wild-type
and mutant PIAS1 proteins. As shown in figure 2A, both wild-type
and SUMO ligase deficient C350S mutant of PIAS1 interacted
with GST-GATA4 but not GST suggesting that the SUMO ligase
activity is not required for the physical association between
GATA4 and PIAS1. A mutant lacking either the N-terminal 300
amino acids or the C-terminal 170 amino acids (PIAS 1–480)
bound GATA4 suggesting that the N-terminal 300 amino acids
and the C-terminal 170 amino acids of PIAS1 are dispensable for
GATA4 binding. Confirming this observation, the N-terminal 150
amino acid peptide (PIAS 1–150) containing the SAP domain and
a 200 amino acid C-terminal peptide (PIAS 450–650) failed to
interact with GATA4. A mutant containing the centrally located
RING finger domain and lacking the N-terminal 121 amino acids
and the C-terminal 170 amino acids interacted with GATA4
suggesting that the RING finger domain may be involved in the
interaction of PIAS1 with GATA4. This notion was confirmed by
demonstrating that the RING finger domain and a small adjoining
C-terminal region of 60 amino acids encoded by PIAS 300–480
are sufficient for GATA4 binding (Figure 2A). The SUMO ligase
activity of PIAS1 was not required for interaction because a
mutant PIAS1 with C350S mutation that affects the SUMO ligase
activity was comparable to wild-type PIAS1 in binding to GATA4
(Figure 2A).
A reciprocal approach in which GST-PIAS1 fusion protein
immobilized on glutathione agarose beads was used to pull down
35[S]-methionine labeled, in vitro translated wild-type and mutant
GATA4 proteins to map the domains of GATA4 that mediate its
interaction with PIAS1 (Figure 2B). While wild-type GATA4
bound to PIAS1, mutant G4NT3 which has a deletion of the C-
terminal zinc finger domain and the adjoining basic region and the
C-terminal activation domain failed to bind PIAS1 suggesting that
the PIAS1 interacting region is located within these C-terminal
regions of GATA4. In agreement with this data, GATA4 peptide
consisting of the C-terminal zinc finger, the adjoining basic region
and the C-terminal activation domain (G4CT3) was sufficient for
interaction with PIAS1. A deletion of the C-terminal activation
domain (amino acids 335–440 in the construct NT1) did not affect
interaction of GATA4 with PIAS1 suggesting that the C-terminal
zinc finger region and the adjoining basic region may mediate
interaction between GATA4 and PIAS1. Peptides consisting of
solely of the zinc fingers (G4ZF-B) or the basic region and the C-
terminal activation domain (G4CT4) bound to PIAS1 weakly
suggesting that both the second zinc finger and the adjoining basic
region together are required for strong binding to PIAS1.
PIAS1 is recruited to GATA4 target gene promoter
We examined whether the physical association of PIAS1 with
GATA4 leads to recruitment of PIAS1 to IFABP, a GATA4 target
gene, using a ChIP assay. Formaldehyde crosslinked chromatin
isolated from mouse jejunal villus epithelium was sheared,
immunoprecipitated with PIAS1 antibody or a nonimmune goat
antibody (negative control) or acetylated histone H3 (positive
control) and analyzed by PCR using primers that span the IFABP
promoter. As shown in the figure 3A, DNA corresponding to
IFABP promoter was immunoprecipitated by PIAS1 antibody
demonstrating that PIAS1 is recruited to IFABP promoter. An
exon 3 to exon 4 region of the IFABP was not precipitated by
PIAS1 antibody indicating that association of PIAS1 with DNA
bound GATA4 may be required for recruitment of PIAS1 to
IFABP chromatin (Figure 3B).
PIAS1 differentially coactivates GATA4 target gene
promoters
Since PIAS1 interacted with GATA4 and recruited to the
IFABP promoter, a GATA4 target, we examined if PIAS1
modulates the transcriptional activity of GATA4. As shown in the
figure 4A, PIAS1 strongly enhanced the activation of IFABP
promoter by GATA4 demonstrating that PIAS1 is a coactivator of
GATA4. This coactivation was dependent on GATA4 binding to
DNA because a mutation at the 240 GATA site that we have
shown previously to mediate the activation of the promoter by
GATA4 [5], abolished synergistic activation by GATA4 and
PIAS1. We further examined if PIAS1 coactivates other GATA4
target promoters such as, LPH and SI. In HCT116 cells, the basal
activity of LPH promoter was lower compared with that of SI
promoter. Despite the differences in the basal promoter activity,
both promoters were activated approximately 2-fold by GATA4.
Interestingly, the activity of SI promoter but not the LPH
promoter was enhanced by PIAS1 (Figure 4B). Together these
results suggest that PIAS1 coactivates a subset of GATA4 target
Figure 4. GATA4 and PIAS1 selectively coactivate GATA4
target promoters. Subconfluent HCT116 cells were transfected with
pCGN empty vector or GATA4 or PIAS1 or GATA4 and PIAS1 together
along with IFABP promoter or IFABP promoter with mutated GATA4
binding site or pGL3 basic luciferase reporters (panel A). In panel B,
LPH promoter and SI promoter luciferase reporters were used. Lysates
were assayed for luciferase activity 48 hours post-transfection. Results
from 3 experiments done in triplicates are shown as mean6SEM.
*p,0.05 for GATA4 transfected cells compared with pCGN transfected
cells. **p,0.05 for GATA4 and PIAS1 cotransfected cells compared with
GATA4 transfected cells.
doi:10.1371/journal.pone.0035717.g004
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promoters.
Mapping of GATA4 and PIAS1 domains required for
IFABP coactivation
We determined the domains of GATA4 required for IFABP
coactivation by transfecting GATA4 deletion mutants along with
PIAS1 and IFABP promoter-luciferase reporter into HCT116
cells. Deletion of the N-terminal activation domains abolished
synergism between GATA4 and PIAS1 (Figure 5A). As noted
earlier [5], GATA4 with a deletion of the C-terminal conforma-
tion-dependent activation domain activated IFABP promoter
more strongly than the wild-type GATA4, yet this mutant failed
to synergistically activate IFABP. A mutant consisting of only the
N- and C-terminal zinc fingers was not sufficient for coactivation.
Deletion of the DNA binding C-terminal zinc finger abolished
synergism between GATA4 and PIAS1. Together these results
suggest that the N- and C-terminal activation domains as well as
DNA binding by GATA4 are required for coactivation of IFABP
by GATA4 and PIAS1.
To map the domains of PIAS1 required for coactivation with
GATA4, we used PIAS1 deletion mutants. As shown in the
figure 5B, the N-terminal SAP domain and the adjacent 30 amino
acids did not support coactivation (PIAS1 1–150). The coactiva-
tion was reduced by 50% for mutants that lacked either the C-
terminal 170 amino acids (PIAS1 1–480) or both the C-terminal
170 amino acids and the N-terminal 120 amino acids (PIAS1 121–
480). A common feature of these 2 mutants is the RING domain
and the adjacent N-terminal 180 amino acids. Deletion of these
180 amino acids in the construct PIAS1 300–450, which has intact
RING domain, abolished coactivation suggesting that these 180
amino acids are required for coactivation. Coactivation was not
Figure 5. Mapping of GATA4 and PIAS1 domains required for IFABP coactivation. Transient cotransfections were performed in
subconfluent HCT116 cells using wild-type and deletion mutants of GATA4 and wild-type PIAS1 (panel A). In panel B, wild-type and deletion
mutants of PIAS1 and wild-type GATA4 were used for cotransfections. Lysates were assayed for luciferase activity 48 hours post-transfection. Results
from 3 experiments done in triplicates are shown as mean6SEM.
doi:10.1371/journal.pone.0035717.g005
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domain and the entire C-terminal domain. The C-terminal
domain (PIAS1 450–650) by itself was not sufficient for
coactivation. Together, these results indicate that while the
centrally located RING domain and the adjacent N-terminal
180 amino acids are sufficient for coactivation, maximal coactiva-
tion requires additional domains located at the N- and C- terminus
of PIAS1.
GATA4 is sumoylated and PIAS1 promotes GATA4
sumoylation
PIAS1 is a SUMO E3 ligase. Since GATA4 physically
interacted with PIAS1, we examined if GATA4 is sumoylated in
intestinal epithelial cells and if PIAS1 promotes GATA4
sumoylation. To determine if the endogenous GATA4 is
sumoylated in intestinal epithelial cells, lysates prepared from the
rat jejunal crypt-derived IEC-6 cells were IPd with goat GATA4
antibody and the IPs were analyzed by probing with mouse
GATA4 and rabbit SUMO-1 antibodies. GATA4 antibody
recognized a major 50 kD band (the expected size of GATA4)
and a minor slow migrating band of approximately 70 kD. The
SUMO-1 antibody recognized this 70 kD band suggesting that
this band corresponds to SUMO modified GATA4 (Figure 6A).
Additionally, we cotransfected HCT116 colon epithelial cells with
HA epitope tagged GATA4 and FLAG epitope tagged SUMO-1
and the cell lysates were IPd with mouse HA antibody and
analyzed by western blotting with a rabbit HA antibody. As shown
in the figure 6B, top panel, cotransfection of HA epitope tagged
GATA4 and FLAG epitope tagged SUMO-1 resulted in the
appearance of a slow migrating GATA4 band. This slow
migrating GATA4 band reacted with the FLAG antibody
suggesting that the slow migrating GATA4 band corresponds to
SUMO modified GATA4 (Figure 6B, lower panel). Further, this
slow migrating GATA4 band was absent when a GATA4K366R,
which has the SUMO acceptor lysine 366 mutated to arginine,
was used for transfection instead of the wild-type GATA4. These
results are consistent with a previous study that demonstrated that
GATA4 is sumoylated on K366 in HeLa cervical carcinoma cells
and cardiac myocytes [23]. Since PIAS1 is a SUMO E3 ligase for
Figure 6. GATA4 is sumoylated and PIAS1 promotes GATA4 sumoylation. Panel A. IEC-6 cell lysates prepared in the presence of 20 mM N-
ethyl maleimide were immunoprecipitated with nonimmune goat or goat GATA4 antibody. IPs were divided in to 2 and analyzed by blotting with
rabbit SUMO-1 antibody (left panel) and mouse GATA4 antibody (right panel). Panel B. Top panel: HCT116 cells were transfected with HA epitope
tagged wild-type or K366R mutated GATA4 with or without FLAG epitope tagged SUMO-1. Lysates were prepared in buffer containing 20 mM N-
ethyl maleimide and equal amounts of lysates were immunoprecipitated with mouse HA antibody. Immunoprecipitates (lanes 3,4,7,8) and
corresponding input controls (lanes 1,2,5,6) were analyzed by western blotting with rabbit HA antibody. Nonsumoylated GATA4 and sumoylated
GATA4 are indicated, respectively, by arrow and arrowhead. Bottom panel: The blot shown in the top panel was stripped and reprobed with rabbit
FLAG antibody. The dark smear in the input controls representing cellular sumoylated proteins is indicated by asterisk. Arrowhead points to the
sumoylated GATA4. Panel C. Top panel: HA epitope tagged GATA4 was transfected with SUMO-1 and PIAS1 as indicated. Cell lysates were prepared
and immunoprecipitated with mouse HA antibody as indicated in panel A and analyzed by western blotting with rabbit HA antibody. Nonsumoylated
GATA4 and sumoylated GATA4 are indicated, respectively, by arrow and arrowhead. Bottom panel: The blot shown in the top panel was stripped and
reprobed with goat PIAS1 antibody.
doi:10.1371/journal.pone.0035717.g006
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associated with GATA4 via the RING finger domain, we
examined whether PIAS1 promotes GATA4 sumoylation in
intestinal epithelial cells by cotransfecting wild-type PIAS1 or
SUMO ligase deficient, C350S mutated PIAS1 along with HA
epitope tagged GATA4 and SUMO-1 into HCT116 cells. As
shown in the figure 6B, top panel, PIAS1 promoted GATA4
sumoylation. PIAS1C350S mutant PIAS1 failed to do so (data not
shown).
Sumoylation is not required for nuclear localization of
GATA4 in intestinal epithelial cells
Previously it was shown that sumoylation is an important
determinant of GATA4 nuclear localization [23]. Abolishing
GATA4 sumoylation by mutating the SUMO acceptor K365 or
interfering with GATA4 sumoylation by knocking down the
obligatory SUMO E2 conjugase, Ubc9, prevented GATA4
nuclear localization in HeLa cervical carcinoma cells. We
examined whether GATA4 nuclear localization in intestinal
epithelial cells is also dependent on sumoylation by immunoflu-
orescence analysis of HCT116 and IEC-6 cells transfected with
HA tagged wild-type or K366R mutated GATA4. In both
HCT116 cells (Figure 7) and IEC-6 cells (data not shown) K366R
mutant GATA4 was localized to the nucleus, similar to wild-type
GATA4 suggesting that sumoylation is dispensable for GATA4
nuclear localization in intestinal epithelial cells. Further, cyclo-
heximide chase experiments indicated that both wild-type and
K366R mutated GATA4 have similar protein half lives suggesting
that sumoylation does not affect GATA4 protein stability (data not
shown).
Neither GATA4 sumoylation nor PIAS1 SUMO ligase
activity is required for coactivation of IFABP promoter
SUMO modification of GATA4 is essential for transactivation
of cardiac tissue-restricted GATA4 target genes and GATA4
induced cardiomyogenic differentiation of 10T1/2 fibroblasts
[23]. To examine whether GATA4 sumoylation is also important
for the transactivation of GI expressed promoters in intestinal
epithelial cells we cotransfected HCT116 cells with IFABP
promoter-luciferase reporter along with wild-type or nonsumoy-
latable K365R mutated GATA4. As shown in the figure 8A and
8C, GATA4K366R activated the IFABP promoter more strongly
than the wild-type GATA4 indicating that transactivation of GI
promoter by GATA4 is independent of sumoylation. Since
SUMO modification on GATA4 was not required for transactiva-
tion, we analyzed whether the SUMO ligase activity of PIAS1 was
required for coactivation of IFABP promoter. SUMO ligase
deficient PIAS1 C350S mutant was comparable to wild-type
PIAS1 for IFABP promoter coactivation (Figure 8B). Further, the
C350S mutated PIAS1 synergized with non sumoylatable K366R
mutated GATA4 (Figure 8C). Together these results show that
neither GATA4 sumoylation nor the PIAS1 SUMO ligase activity
is required coactivation of IFABP promoter.
Discussion
GATA4 regulation of cell-type-specific gene expression is
achieved through the combinatorial interaction of GATA4 with
various ubiquitous and cell-type-enriched transcriptional regula-
tors and coregulators [1]. Our study has determined that PIAS1 is
an intestine-expressed GATA4 partner protein.
GATA4 and PIAS1 physically associated with each other as
demonstrated by interaction assays performed in yeast or in
mammalian cells or in vitro. The physical association involved the
second zinc finger and the adjacent basic region of GATA4 and
the RING finger and the adjoining C-terminal sequences of
PIAS1. The physical association enabled GATA4 and PIAS1 to
synergistically activate IFABP promoter. Since this synergism was
dependent on GATA4 binding to DNA, the results suggested that
PIAS1 was recruited to IFABP promoter via its interaction with
GATA4. In addition to IFABP, SI, a known GATA4 dependent
promoter was also synergistically activated. However, not all
GATA4-dependent promoters were coactivated by GATA4 and
PIAS1. For example, LPH promoter was activated by GATA4 but
failed to be coactivated by GATA4 and PIAS1 suggesting that the
selective recruitment of PIAS1 to GATA4-dependent promoters
may determine the expression levels of specific promoters.
Considering that PIAS1 can bind to chromatin through its SAP
domain and localize to nuclear speckles often considered to be sites
of active chromatin [27], it is possible that in the context of
chromatin under in vivo conditions, PIAS1 may associate with
Figure 7. Sumoylation is not required for nuclear localization of GATA4. HCT116 cells plated on coverslips were transfected with HA
epitope tagged GATA4 (panels A,B,C) or K366R mutated GATA4 (panels D,E,F). Cells were fixed, permeabilized and stained with rabbit HA antibody
and Alexa 594 conjugated anti rabbit secondary antibody. Coverslips were mounted with DAPI-containing mounting media and analyzed for
immunofluorescence.
doi:10.1371/journal.pone.0035717.g007
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recruit GATA4.
There are many factors known to interact with GATA4 and
regulate GATA4 transcriptional activity [28]. A majority of these
interacting proteins such as, SRF [29], Nkx2-5 [30,31], TBX5
[32], Hand2 [33], Sp1 [34], SF1 [35], HNF1 alpha [9], Smads
[5,36] and Fog2 [19], may work as part of transcriptional
complexes involving GATA4. Several other partners of GATA4
such as, p300 [37], HDAC2 [38], Erk-1/2 [39], p38 MAP kinase
[40], protein kinase A [41], and protein kinase C [42] act by both
associating with and inducing or eliminating posttranslational
modifications on GATA4 protein. PIAS1 belongs to the latter
group that both interacts with and modifies GATA4. Interestingly,
GATA4 modification was not required for GATA4 transcriptional
activity and preventing GATA4 modification did not affect
nuclear localization of GATA4. Further, PIAS1 SUMO ligase
activity was not required for coactivation. These observations
contrast with that of Wang et al [23], who showed that
sumoylation regulates nuclear localization and transcriptional
activation functions of GATA4 and the SUMO ligase activity of
PIAS1 is important for synergy between GATA4 and PIAS1. This
discrepancy could be due to the differences in the gene promoters
analyzed and the cell types used. These contrasting observations
point to a fundamentally different mechanism by which SUMO
pathway components regulate GATA4 activity in cardiac and GI
cell types resulting in distinct outcomes. There is also precedence
that SUMO ligases can regulate gene expression independently of
their SUMO ligase activities [43]. For example, SF1, a GATA4
partner protein, is sumoylated and its sumoylation is promoted by
PIAS1 and PIAS3 [44]. Sumoylation regulates the transcriptional
activities of SF-1. PIAS1 can enhance transcriptional activity of
SF-1 on select SF-1 target promoters but not all SF-1 target
promoters and independent of SUMO ligase activity [45].
Although sumoylation per se is not required for GATA4
transactivation of IFABP promoter, SUMO may have a role in
regulating GATA4 activity. We have found that both wild-type
and nonsumoylatable K366R mutated GATA4 synergizes with
SUMO-1 to activate IFABP promoter (unpublished observations).
This synergism may be mediated via non covalent interactions
between GATA4 and SUMO-1. SUMO-interaction motif (SIM),
a loose consensus consisting of a core of yy6y or y6yy (where y
is a hydrophobic amino acid and x is any amino acid) often with a
cluster of acidic amino acids at the C-terminus mediates such non
covalent interactions [43,46]. Several such loose consensus
sequences (LDMFDD and LYMKL) are present in GATA4.
Non covalent interactions between such potential SIMs in GATA4
and SUMO proteins and other sumoylated GATA4 partner
proteins may be important for regulation of GATA4 mediated
gene expression in GI epithelial cells.
Transcriptional activity of several factors has been shown to be
limited by a stretch of amino acids of consensus sequence ‘‘P-
X(0,4)-I/V-K-Q/T/S/L/E/P-E-X(0,3)-P’’, termed synergy control
(SC) motif, the deletion of or mutations in which enhances
transcriptional activity by allowing transcriptional regulators to
work in synergy [47]. GATA4 has such a motif in the C-terminus
and deletion of the C-terminus that consists of this motif increased
transcriptional activity of GATA4 (Figure 5A, labeled GA-
TA4DC). Subsequently, the core of the SC motif, ‘‘YxKE’’ was
determined to be a consensus sequence for sumoylation [48]. In
GATA4 a mutation of K366 that disrupts the SC consensus/
sumoylation sequence increased transcriptional activity of GATA4
Figure 8. GATA4 sumoylation and PIAS1 SUMO ligase activity
is required for coactivation of IFABP promoter. Panel A.
Subconfluent HCT116 cells were transfected with pCGN empty vector
or wild-type GATA4 or K366R mutated GATA4 along with IFABP
promoter or IFABP promoter with mutated GATA4 binding site or pGL3
basic luciferase reporters. Lysates were assayed for luciferase activity
48 hours post-transfection. Results from 3 experiments done in
triplicates are shown as mean6SEM. *p,0.05 for GATA4 transfected
cells compared with pCGN transfected cells. **p,0.05 for GATA4K366R
transfected cells compared with GATA4 transfected cells. Panel B.
Transient transfections in HCT116 cells were carried out as indicated in
panel A with GATA4 or PIAS1 or C350S mutated PIAS1 individually or in
combination as shown. *p,0.05 for GATA4 transfected cells compared
with pCGN transfected cells. **p,0.05 for GATA4 and PIAS1/
PIAS1C350S cotransfected cells compared with GATA4 transfected
cells. Panel C. Transfections were performed in HCT116 cells as
indicated in panel A using GATA4 or K366R mutants with or without
PIAS1. *p,0.05 for GATA4 transfected cells compared with pCGN
transfected cells. **p,0.05 for GATA4/PIAS1 and GATA4K366R/PIAS1
cotransfected cells compared with GATA4 and GATA4K366R transfected
cells. ***p,0.05 for GATA4K366R transfected cells compared with
GATA4 transfected cells.
doi:10.1371/journal.pone.0035717.g008
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activity of this motif can be modulated by sumoylation, which is
dynamic and readily reversible. Considering that SUMO moiety
recruits several corepressor activities that can epigenetically
remodel chromatin [49–52], GATA4 sumoylation site provides a
platform dependent on which sumoylated GATA4 may repress
gene expression while nonsumoylated GATA4 will serve as an
activator of gene expression. Several transcriptional regulators
such as, Elk-1, Sp3 and p300, serve as both activators and
repressors, depending on their sumoylation status [51–53].
Existence of a GATA4 sumoylation switch-dependent mutually
exclusive gene programs may help explain the role of GATA4 in
establishing and maintaining jejunal identity. Intestine-specific
inactivation of GATA4 has revealed that GATA4 is essential for
activating a jejunum-specific gene program while simultaneously
repressing a ileum-specific gene program [2,3]. The repression of
ileal gene program in jejunum was dependent on the interaction of
GATA4 with GATA4 cofactor, Fog1 [18], a protein that binds
repressor complexes in a sumoylation-dependent manner and
differentially regulates erythroid differentiation program of
GATA1 [54]. These observations add to the credence that
nonsumoylated GATA4 may promote jejunum-specific gene
expression while sumoylated GATA4, capable assembling core-
pressor complexes, may repress ileum-specific gene program.
In GI epithelial cells sumoylation is an important posttransla-
tional modification essential for determination and differentiation
of intestinal epithelial cell types. A recent study showed that an
inducible ablation of Ubc9, the only E2 SUMO conjugase activity
essential for sumoylation of all SUMO substrates, affected
enterocyte differentiation, shortened villus height and increased
the villus goblet cell population [55]. This phenotype partially
resembles the intestine-specific GATA4, GATA6 and compound
GATA4/GATA6 ablation phenotypes characterized by shortened
villus height, reduced crypt cell proliferation, increased goblet cell
numbers and impaired jejunal enterocyte differentiation program
[2,3,56]. The similarity in the intestinal phenotype between Ubc9,
which eliminates sumoylation globally, and GATA4/GATA6 loss
of function suggests that SUMO modification of GATA4 and
other sumoylatable intestinal transcriptional regulators may be
important for their intestinal epithelial cell-type determination and
differentiation activities.
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